Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 72 | 72 | 72 | 72 | 71 |
| Cost of Goods | 44 | 6 | 6 | 6 | 5 |
| Gross Profit | 28 | 66 | 66 | 66 | 66 |
| Operating Expenses | 4,353 | 4,778 | 3,928 | 3,700 | 2,816 |
| Operating Income | -4,281 | -4,706 | -3,856 | -3,628 | -2,744 |
| Interest Expense | 37 | 5 | 5 | 2 | 3 |
| Other Income | 90 | 318 | 229 | -278 | 6,929 |
| Pre-tax Income | -4,228 | -4,393 | -3,631 | -3,907 | 4,182 |
| Income Tax | N/A | N/A | N/A | N/A | 25 |
| Net Income Continuous | -4,228 | -4,393 | -3,631 | -3,907 | 4,157 |
| Net Income Discontinuous | N/A | N/A | -70 | -1 | -253 |
| Net Income | $-4,228 | $-4,393 | $-3,701 | $-3,909 | $3,904 |
| EPS Basic Total Ops | -0.50 | -1.19 | -1.20 | -1.71 | 1.32 |
| EPS Basic Continuous Ops | -0.50 | -1.19 | -1.18 | -1.71 | 1.45 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.02 | 0.00 | -0.13 |
| EPS Diluted Total Ops | -0.50 | -1.19 | -1.20 | -1.71 | 1.32 |
| EPS Diluted Continuous Ops | -0.50 | -1.19 | -1.18 | -1.71 | 1.43 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.02 | 0.00 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.50 | -1.19 | -1.18 | N/A | N/A |
| EBITDA(a) | $-4,269 | $-4,700 | $-3,766 | $-3,628 | $-2,636 |